CoChat

Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models

Open access
Cullen, Nicholas C., Janelidze, Shorena, Mattsson‐Carlgren, Niklas, Palmqvist, Sebastian, Bittner, Tobias, Suridjan, Ivonne, Jethwa, Alexander, Kollmorgen, Gwendlyn, Brum, Wagner S., Zetterberg, Henrik, Blennow, Kaj, Stomrud, Erik, Hansson, Oskar · 2023 · Alzheimer's & Dementia
Cited by 84

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Introduction: The effect of random error on the performance of blood‐based biomarkers for Alzheimer's disease (AD) must be determined before clinical implementation. Methods: We measured test‐retest variability of plasma amyloid beta (Aβ)42/Aβ40, neurofilament light (NfL), glial fibrillary acidic protein (GFAP), and phosphorylated tau (p‐tau)217 and simulated effects of this variability on biomarker performance when predicting either cerebrospinal fluid (CSF) Aβ status or conversion to AD dementia in 399 non‐demented participants with cognitive symptoms. Results: Clinical performance was highest when combining all biomarkers. Among single‐biomarkers, p‐tau217 performed best. Test‐retest variability ranged from 4.1% (Aβ42/Aβ40) to 25% (GFAP). This variability reduced the performance of the biomarkers (≈ΔAUC [area under the curve] −1% to −4%) with the least effects on models with p‐tau217. The percent of individuals with unstable predicted outcomes was lowest for the multi‐biomarker combination (14%). Discussion: Clinical prediction models combining plasma biomarkers—particularly p‐tau217—exhibit high performance and are less effected by random error. Individuals with unstable predicted outcomes (“gray zone”) should be recommended for further tests.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12706

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 84

Metadata

Authors
Cullen, N. C., Janelidze, S., Mattsson‐Carlgren, N., Palmqvist, S., Bittner, T., Suridjan, I., Jethwa, A., Kollmorgen, G., Brum, W. S., Zetterberg, H., Blennow, K., Stomrud, E., & Hansson, O.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2022-06-14
Volume
19
Issue
3
Pages
797-806
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4282913972
Cited by
84
References
11
FWCI
10.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.